VIVOXID LTD Company Profile
Vivoxid Ltd develops, manufactures and markets new generation biomaterial products and production services within the medical device sector.
Vivoxid markets its MetAlive™ technologies for soft tissue attachment of implants, AbMin™ bioactive glass and its biodegradable polymer composite products in bone reconstruction and Cellonex™ cellulose dressing products in wound management.
Vivoxid is on the verge of international expansion. The main equity investors are Sitra, Varma Mutual Pension Insurance Company and Sentica Partners Ltd. The company is located in Turku, Finland. Vivoxid was founded in 2001. The company's dynamic business operations are based on its extensive combined knowledge of both biomaterials and tissue regeneration. Vivoxid has a strong IPR position, effective networking and experienced personnel.
Vivoxid takes part in research and development projects with different departments and runs its own R&D with scientists from universities. The company has a wide patent portfolio covering its core technology
Tykistökatu 4 A
Phone: 358 20 7622 266
Fax: 358 20 7622 262
Drugs and Medications
Vivoxid Ltd develops, manufactures and markets new generation biomaterial products and production services within the medical device sector. Vivoxid markets its MetAlive™ technologies for soft tissu...
More Information about "VIVOXID LTD" on BioPortfolio
We have published hundreds of VIVOXID LTD news stories on BioPortfolio along with dozens of VIVOXID LTD Clinical Trials and PubMed Articles about VIVOXID LTD for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of VIVOXID LTD Companies in our database. You can also find out about relevant VIVOXID LTD Drugs and Medications on this site too.